Cyclopentylacrylamide derivative
AssigneesKyorin Pharmaceutical Co., Ltd., Teijin Pharma Limited
InventorsYasumichi FUKUDA, Yoshikazu ASAHINA, Masanori TAKADOI, Masanori YAMAMOTO
Life of this patent
Estimating the term…
Loading patent…
AssigneesKyorin Pharmaceutical Co., Ltd., Teijin Pharma Limited
InventorsYasumichi FUKUDA, Yoshikazu ASAHINA, Masanori TAKADOI, Masanori YAMAMOTO
Estimating the term…
A compound having a hypoglycemic effect is provided. The compound and a pharmaceutically acceptable salt thereof are useful for the treatment or prevention of diabetes, obesity, and the like. The compound is represented by the general formula (1): (wherein R1 and R2 are each independently a hydrogen atom, a halogen atom, an amino group, a hydroxyl group, a hydroxyamino group, a nitro group, a cyano group, a sulfamoyl group, a C1 to C6 alkyl group, a C1 to C6 alkoxy group, a C1 to C6 alkylsulfanyl group, a C1 to C6 alkylsulfinyl group, a C1 to C6 alkylsulfonyl group, or a C1 to C6 alkoxy-C1 to C6 alkylsulfonyl group, and A is a substituted or unsubstituted heteroaryl group).
1-22. (canceled)
A compound represented by the general formula (2):
Dependencies are inferred from the claim text.